Discovery of OT4003, a novel, potent, and orally active cys-LT1 receptor antagonist
The present paper describes the structural modifications leading to the discovery of a new series of quinoline-containing cys-LT1 receptor (LTD4 receptor) antagonists. A structural optimization with respect to the in vitro receptor b